BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18205948)

  • 41. Tumor suppressor protein p53 recruits human Sin3B/HDAC1 complex for down-regulation of its target promoters in response to genotoxic stress.
    Bansal N; Kadamb R; Mittal S; Vig L; Sharma R; Dwarakanath BS; Saluja D
    PLoS One; 2011; 6(10):e26156. PubMed ID: 22028823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.
    Müller-Tidow C; Steffen B; Cauvet T; Tickenbrock L; Ji P; Diederichs S; Sargin B; Köhler G; Stelljes M; Puccetti E; Ruthardt M; deVos S; Hiebert SW; Koeffler HP; Berdel WE; Serve H
    Mol Cell Biol; 2004 Apr; 24(7):2890-904. PubMed ID: 15024077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
    Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW
    Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AML1/ETO induces self-renewal in hematopoietic progenitor cells via the Groucho-related amino-terminal AES protein.
    Steffen B; Knop M; Bergholz U; Vakhrusheva O; Rode M; Köhler G; Henrichs MP; Bulk E; Hehn S; Stehling M; Dugas M; Bäumer N; Tschanter P; Brandts C; Koschmieder S; Berdel WE; Serve H; Stocking C; Müller-Tidow C
    Blood; 2011 Apr; 117(16):4328-37. PubMed ID: 21245488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription.
    Kumar R; Manning J; Spendlove HE; Kremmidiotis G; McKirdy R; Lee J; Millband DN; Cheney KM; Stampfer MR; Dwivedi PP; Morris HA; Callen DF
    Mol Cancer Res; 2006 Sep; 4(9):655-65. PubMed ID: 16966434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The ETO (MTG8) gene family.
    Davis JN; McGhee L; Meyers S
    Gene; 2003 Jan; 303():1-10. PubMed ID: 12559562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ETO/MTG8 is an inhibitor of C/EBPbeta activity and a regulator of early adipogenesis.
    Rochford JJ; Semple RK; Laudes M; Boyle KB; Christodoulides C; Mulligan C; Lelliott CJ; Schinner S; Hadaschik D; Mahadevan M; Sethi JK; Vidal-Puig A; O'Rahilly S
    Mol Cell Biol; 2004 Nov; 24(22):9863-72. PubMed ID: 15509789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
    Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G
    Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of the transforming growth factor beta 1 signaling pathway by the AML1/ETO leukemia-associated fusion protein.
    Jakubowiak A; Pouponnot C; Berguido F; Frank R; Mao S; Massague J; Nimer SD
    J Biol Chem; 2000 Dec; 275(51):40282-7. PubMed ID: 11032826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells.
    Era T; Asou N; Kunisada T; Yamasaki H; Asou H; Kamada N; Nishikawa S; Yamaguchi K; Takatsuki K
    Genes Chromosomes Cancer; 1995 May; 13(1):25-33. PubMed ID: 7541640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.
    Bakshi R; Zaidi SK; Pande S; Hassan MQ; Young DW; Montecino M; Lian JB; van Wijnen AJ; Stein JL; Stein GS
    J Cell Sci; 2008 Dec; 121(Pt 23):3981-90. PubMed ID: 19001502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain.
    Durst KL; Lutterbach B; Kummalue T; Friedman AD; Hiebert SW
    Mol Cell Biol; 2003 Jan; 23(2):607-19. PubMed ID: 12509458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Domains involved in ETO and human N-CoR interaction and ETO transcription repression.
    Wang J; Wang M; Liu JM
    Leuk Res; 2004 Apr; 28(4):409-14. PubMed ID: 15109542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure and expression of the human MTG8/ETO gene.
    Wolford JK; Prochazka M
    Gene; 1998 May; 212(1):103-9. PubMed ID: 9661669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mtgr1 is a transcriptional corepressor that is required for maintenance of the secretory cell lineage in the small intestine.
    Amann JM; Chyla BJ; Ellis TC; Martinez A; Moore AC; Franklin JL; McGhee L; Meyers S; Ohm JE; Luce KS; Ouelette AJ; Washington MK; Thompson MA; King D; Gautam S; Coffey RJ; Whitehead RH; Hiebert SW
    Mol Cell Biol; 2005 Nov; 25(21):9576-85. PubMed ID: 16227606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the ETO and AML1-ETO proteins involved in 8;21 translocation in acute myelogenous leukemia.
    Le XF; Claxton D; Kornblau S; Fan YH; Mu ZM; Chang KS
    Eur J Haematol; 1998 Apr; 60(4):217-25. PubMed ID: 9579874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development.
    Yan M; Burel SA; Peterson LF; Kanbe E; Iwasaki H; Boyapati A; Hines R; Akashi K; Zhang DE
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17186-91. PubMed ID: 15569932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO.
    Berg T; Fliegauf M; Burger J; Staege MS; Liu S; Martinez N; Heidenreich O; Burdach S; Haferlach T; Werner MH; Lübbert M
    Haematologica; 2008 Nov; 93(11):1728-33. PubMed ID: 18790797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias.
    Mao S; Frank RC; Zhang J; Miyazaki Y; Nimer SD
    Mol Cell Biol; 1999 May; 19(5):3635-44. PubMed ID: 10207087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leukemogenic AML1-ETO fusion protein increases carcinogen-DNA adduct formation with upregulated expression of cytochrome P450-1A1 gene.
    Xu M; Li D; Lu Y; Chen GQ
    Exp Hematol; 2007 Aug; 35(8):1249-55. PubMed ID: 17560011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.